Prostate-specific membrane antigen (PSMA) PET/CT has become an unparalleled modality in the diagnosis of primary and recurrent prostatic adenocarcinoma, often revealing sites of disease that were previously invisible on conventional imaging. In this 78-year-old man with suspected prostate cancer recurrence, PSMA PET/CT revealed focal radiotracer uptake in the brain, which would ordinarily raise suspicion for metastases, but was a false positive in the setting of a recent stroke. Increased PSMA uptake has been reported in subacute infarcts and primary and secondary brain tumors. Careful history and comparison with prior imaging are vital to avoid false-positive diagnosis in such patients.
Keyphrases
- pet ct
- prostate cancer
- radical prostatectomy
- high resolution
- positron emission tomography
- end stage renal disease
- newly diagnosed
- pet imaging
- chronic kidney disease
- benign prostatic hyperplasia
- atrial fibrillation
- acute myocardial infarction
- prognostic factors
- cerebral ischemia
- pulmonary embolism
- heart failure
- resting state
- multiple sclerosis
- coronary artery disease
- functional connectivity
- rectal cancer